Physician profile

Joseph Mackey

Internal Medicine · Plainview, NY

NPI 1063429371

$701.80

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kowa Pharmaceuticals America, INC. $113.45 2019-2021
Abbvie INC. $108.33 2021
Pfizer INC. $80.10 2019-2021
Merck Sharp & Dohme LLC $75.30 2019-2020
Janssen Pharmaceuticals, INC $60.96 2019-2020
Boehringer Ingelheim Pharmaceuticals, INC. $50.74 2019-2020
Novartis Pharmaceuticals Corporation $30.11 2019
Esperion Therapeutics, INC. $27.27 2020
Astrazeneca Pharmaceuticals Lp $25.93 2019-2020
Ultragenyx Pharmaceutical INC. $22.25 2021
Amarin Pharma, INC. $19.79 2020
Lilly USA, LLC $19.58 2020
Genentech USA, INC. $16.18 2019
E.R. Squibb & Sons, L.L.C. $14.20 2021
Seqirus USA INC $13.66 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Amgen INC. $12.71 2020
Astellas Pharma US INC $11.24 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Mackey

$701.80

in general payments reported 2019-2025

Years
2019-2021
Top company
Kowa Pharmaceuticals America, INC.

https://glasscript.com/doctor/321006/joseph-mackey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.